- Home
- BLIN vs ATHA Comparison
BLIN vs ATHA Comparison
Compare BLIN & ATHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLIN
- ATHA
- Stock Information
- Founded
- BLIN 2000
- ATHA 2011
- Country
- BLIN United States
- ATHA United States
- Employees
- BLIN N/A
- ATHA N/A
- Industry
- BLIN EDP Services
- ATHA Medicinal Chemicals and Botanical Products
- Sector
- BLIN Technology
- ATHA Health Care
- Exchange
- BLIN Nasdaq
- ATHA Nasdaq
- Market Cap
- BLIN 16.5M
- ATHA 14.8M
- IPO Year
- BLIN 2007
- ATHA 2020
- Fundamental
- Price
- BLIN N/A
- ATHA $3.74
- Analyst Decision
- BLIN Strong Buy
- ATHA
- Analyst Count
- BLIN 1
- ATHA 0
- Target Price
- BLIN $4.62
- ATHA N/A
- AVG Volume (30 Days)
- BLIN 209.5K
- ATHA 48.3K
- Earning Date
- BLIN 08-14-2025
- ATHA 11-06-2025
- Dividend Yield
- BLIN N/A
- ATHA N/A
- EPS Growth
- BLIN N/A
- ATHA N/A
- EPS
- BLIN N/A
- ATHA N/A
- Revenue
- BLIN $15,375,000.00
- ATHA N/A
- Revenue This Year
- BLIN $2.45
- ATHA N/A
- Revenue Next Year
- BLIN $16.36
- ATHA N/A
- P/E Ratio
- BLIN N/A
- ATHA N/A
- Revenue Growth
- BLIN 0.54
- ATHA N/A
- 52 Week Low
- BLIN $1.05
- ATHA $2.20
- 52 Week High
- BLIN $2.80
- ATHA $8.26
- Technical
- Relative Strength Index (RSI)
- BLIN 54.45
- ATHA 60.55
- Support Level
- BLIN $1.35
- ATHA $3.61
- Resistance Level
- BLIN $1.59
- ATHA $4.04
- Average True Range (ATR)
- BLIN 0.08
- ATHA 0.25
- MACD
- BLIN 0.01
- ATHA -0.17
- Stochastic Oscillator
- BLIN 49.19
- ATHA 7.14
About BLIN Bridgeline Digital Inc.
Bridgeline Digital Inc is a AI-powered marketing technology company that offers a suite of products that help companies grow online revenue by driving more traffic to their websites, converting more visitors to purchasers, and increasing average order value. Company software is available through a cloud-based Software as a Service (SaaS) model. It helps to maximize the performance of critical websites, intranets, and online stores. The company generates revenue from digital engagement services, subscription, perpetual licenses, maintenance, and hosting. Geographically, it derives a majority of revenue from the United States.
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug candidate designed to enhance the activity of the neurotrophic hepatocyte growth factor (HGF) system; ATH-1020 a novel, orally available, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system; ATH-1105 is a novel, orally available, next-generation, small molecule drug candidate designed to positively modulate the neurotrophic HGF system.